Literature DB >> 1324048

Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung.

P D'Orléans-Juste1, S Télémaque, A Claing, M Ihara, M Yano.   

Abstract

Although ET1 and ET2 binding sites were found in rat lung membranes, a selective ET1 receptor antagonist, BQ-123 (10 microM), did not displace [125I]-endothelin-1 ([125I]ET-1) from ET2 sites, illustrating the selectivity of the angatonist for ET1 receptors. In rat perfused lungs, BQ-123 (1 microM) markedly reduced the prostacyclin (PGI2) releasing properties of endothelin-1 (ET-1: 5 nM) and human big-ET-1 (100 nM) suggesting that both peptides induce the release of PGI2 via the selective activation of ET1 receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324048      PMCID: PMC1908696          DOI: 10.1111/j.1476-5381.1992.tb09055.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

Authors:  M Ihara; K Noguchi; T Saeki; T Fukuroda; S Tsuchida; S Kimura; T Fukami; K Ishikawa; M Nishikibe; M Yano
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

2.  An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.

Authors:  M Ihara; T Fukuroda; T Saeki; M Nishikibe; K Kojiri; H Suda; M Yano
Journal:  Biochem Biophys Res Commun       Date:  1991-07-15       Impact factor: 3.575

Review 3.  Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed.

Authors:  D J Webb
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

4.  Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.

Authors:  P D'Orléans-Juste; P S Lidbury; S Telemaque; T D Warner; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

5.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

7.  Inhibition of biological actions of big endothelin-1 by phosphoramidon.

Authors:  T Fukuroda; K Noguchi; S Tsuchida; M Nishikibe; F Ikemoto; K Okada; M Yano
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

8.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  A radioimmunoassay for 6-keto-prostaglandin F1alpha.

Authors:  J A Salmon
Journal:  Prostaglandins       Date:  1978-03
  9 in total
  12 in total

1.  Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.

Authors:  D W Hay; M A Luttmann; W C Hubbard; B J Undem
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

2.  Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Differential effects of BQ-123 against endothelin-1 and endothelin-3 on the rat vas deferens: evidence for an atypical endothelin receptor.

Authors:  A Eglezos; P Cucchi; R Patacchini; L Quartara; C A Maggi; J Mizrahi
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

4.  Endothelin receptors mediating contraction in goat cerebral arteries.

Authors:  J B Salom; G Torregrosa; M D Barberá; T Jover; E Alborch
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

5.  Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.

Authors:  L McMurdo; P S Lidbury; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  A role for endothelin in bicuculline-induced neurogenic pulmonary oedema in rats.

Authors:  C Herbst; B Tippler; H Shams; T Simmet
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  Endothelins induce prostacyclin release in both vascular and non-vascular tissue.

Authors:  G G Mattera; R M Catalioto; M Criscuoli; A Subissi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

9.  Effects of selective ETB-receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle.

Authors:  U Ekelund; M Adner; L Edvinsson; S Mellander
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

10.  Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat.

Authors:  P D'Orléans-Juste; A Claing; T D Warner; M Yano; S Télémaque
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.